MDB — Medicofarma Biotech SA Balance Sheet
0.000.00%
Last trade - 00:00
- PLN57.65m
- PLN57.64m
- PLN0.75m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | PAS | PAS | PAS | PAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.2 | 0.064 | 0.077 | 0.508 | 0.003 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.628 | 0.149 | 1.44 | 0.583 | 0.409 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.18 | 0.387 | 2.08 | 2.26 | 2.55 |
Net Property, Plant And Equipment | 0.027 | 0 | 12.7 | 12.6 | 12.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1.39 | 0.396 | 16.8 | 16.4 | 15.7 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.699 | 0.625 | 0.522 | 3.28 | 4.01 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.701 | 0.625 | 2.56 | 3.76 | 5.78 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 0.687 | -0.229 | 14.2 | 12.6 | 9.94 |
Total Liabilities & Shareholders' Equity | 1.39 | 0.396 | 16.8 | 16.4 | 15.7 |
Total Common Shares Outstanding |